Antimicrobial resistance, AMR, is projected to claim 10 million lives every year by 2050; superbugs with no treatment options. Now experts worry the pandemic has made AMR worse.

Steven Theriault, CEO of local Cytophage Technologies, told 680 CJOB his company is using something called bacteriophage therapy to fight back against anti-microbial resistance.

On this week’s Super Awesome Science Show, we look at how a century-old treatment is being used to fight antibiotic-resistant bacterial infections.